SCHEMBL30453166

SCHEMBL30453166

Cc1c(-c2cccnc2)cnc(C#N)c1OCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 9/20 0.47
CYP11B2 P19099 9/20 0.47
CYP19A1 P11511 5/20 0.47
KDM4E B2RXH2 3/20 0.42
HTT P42858 2/20 0.42
GAA P10253 2/20 0.42
HSD17B10 Q99714 2/20 0.42
ALDH1A1 P00352 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42
MAPK1 P28482 1/20 0.42
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GRM5 P41594 1/20 0.39
SQOR Q9Y6N5 1/20 0.39
IKBKB O14920 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257578 1.00 CYP11B1 (0.47) CYP11B1CYP11B2CYP19A1KDM4EHTT
SCHEMBL29248951 0.89 CYP11B1 (0.57) CYP11B1CYP11B2CYP19A1KDM4EGAA
SCHEMBL30546846 0.89 CYP11B1 (0.57) CYP11B1CYP11B2CYP19A1KDM4EGAA
SCHEMBL30546888 0.88 CYP11B1 (0.42) CYP11B1CYP11B2CYP19A1KDM4EHTT
SCHEMBL24257687 0.88 CYP11B1 (0.42) CYP11B1CYP11B2CYP19A1KDM4EHTT
SCHEMBL24257777 0.87 MAPT (0.42) KDM4EHTTGAAHSD17B10ALDH1A1
SCHEMBL24257768 0.84 SQOR (0.42) CYP11B1CYP11B2KDM4EHTTHSD17B10
SCHEMBL24257771 0.82 GRM5 (0.42) KDM4EMAPTHPGDMAPK1TP53
SCHEMBL24257769 0.82 C5AR1 (0.41) CYP11B1CYP11B2KDM4EHTTHSD17B10
SCHEMBL30546869 0.82 C5AR1 (0.41) CYP11B1CYP11B2KDM4EHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4196466-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2023-06-21 EP disclosed